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Abstract. The adhesion and migration of human dip- 
loid fibroblasts on plasma clots were measured. The 
role of plasma fibronectin was examined by depleting 
plasma of fibronectin before clotting. Fibronectin was 
not essential for cell adhesion and spreading, although 
rates were slightly slower on depleted dots. Rates of 
migration on the surface of clots were unaffected by 
fibronectin depletion. 
In contrast, fibronectin was an absolute requirement 
for migration of cells into plasma clots. Cells migrated 
rapidly into control clots but completely failed to pen- 
etrate the surface of fibronectin-depleted clots. The 
effect of depletion could only be reversed by adding 
fibronectin to depleted plasma before clotting. Ad- 
sorption of fibronectin after dotting failed to reverse 
the effect of depletion, suggesting that fibronectin had 
to be cross-linked by transglutaminase during the clot- 
ting process. 
T 
HE factors involved in fibroblast adhesion and migra- 
tion have been extensively studied. Most studies have 
made use of artificial substrates; these need to have a 
suitably charged surface  (5,  19). In the presence  of serum, 
fibroblasts adhere to such surfaces and spread into a charac- 
teristic bipolar morphology (34). This adhesion and spreading 
is a prerequisite for the proliferation of normal cells (31 ). 
Two plasma proteins can promote cell adhesion. One is 
fibronectin, a 450,000-D  dimeric protein; the structure and 
mechanism of action of this protein are well documented 
(12). The other adhesive protein in plasma is 70,000 D (2, 10, 
16,  17, 30) and is unrelated to fibronectin. Less is presently 
known about this protein but it appears to have a different 
mechanism of action from fibronectin (17). 
During the wound response, fibroblasts and other cell types 
interact with the fibrin lattice of the clot that forms at the site 
of tissue damage. Fibroblasts migrate into certain areas of the 
clot, proliferate,  and synthesize collagen  and other compo- 
nents of the connective tissue extracellular matrix. The adhe- 
sion of cells to adsorbed monomolecular layers of fibrin has 
been studied (9, 23, 24), and fibronectin has been shown to 
increase rates of  attachment and spreading (9). In the clot that 
forms physiologically,  the fibrin is in the form of a  three- 
dimensional lattice.  The fibrin is cross-linked  by transgluta- 
minase, the factor XIII of the clotting cascade which is also 
known to cross-link plasma fibronectin to fibrin (20, 21). 
In this study we have examined the behavior of human 
diploid fibroblasts on plasma clots and in particular the role 
of fibronectin in the adhesion and subsequent migration into 
clots. 
Materials and Methods 
Preparation of Plasma Clots 
Blood was collected  from volunteers  and anticoagulated  with  EDTA  (final 
concentration  3.5 raM). After centrifugation at 5,000 g for l0 rain, plasma was 
aspirated and dialyzed at 4"C against phosphate-buffered saline (PBS). Assays 
of adhesion, spreading, and migration on the surface of  plasma clots were done 
using 35-mm petri dishes. To 1 ml of plasma kept on ice was added  10/zl of 
150 mM CaCI2 and  10 ~1 of 50 IU/ml thrombin. The mixture  was rapidly 
mixed and added to a petri dish which was placed in a 37*C incubator  for 15 
rain to allow dotting to lake place. In some experiments, 24-well dishes were 
used. In this ease, 0.5-ml dots were formed in each well. 
Depletion of  Fibronectin 
10-ml bed  vol  of gelatin-Ultrodex  (LKB,  Selsdon,  Surrey)  was  used. 5-ml 
samples  of plasma  were passed  through each  column before  regeneration. 
Plasma was eluted with PBS, and protein-containing  fractions were pooled and 
concentrated  back  to  starting  volume  using  Amicon  C25  Centriflo  cones 
(Amicon Corp., Danvers, MA). Depleted plasma was dialyzed at 4"C against 
PBS. Before recalcifieation and clotting, the protein  concentration  was mea- 
sured speetrophotometrically at 280 nm. The depleted plasma was adjusted by 
further  concentration  or dilution  to give the same protein  concentration  as 
control  plasma. Clotting  of fibronectin-depleted  plasma was achieved in the 
same way as control  plasma. Purified human fibroneetin was obtained  from 
LKB and was, unless stated otherwise, added back to plasma at 0.3 mg/ml of 
plasma before or after clotting as indicated. 
Cells 
BCL-DI  human diploid  fibroblasts  were  obtained  from Gibco  (Uxbridge, 
Middlesex, UK) and cultured routinely in Ham's F10 medium (Gibco) supple- 
merited with 10% fetal bovine serum (Gibeo). 
Cell Attachment Assay 
Confluent monolayers of BCL-D 1 cells were trypsinized, suspended in serum- 
less FI0 medium, and adjusted to a density of 5 ×  104/ml. l-ml aliquots of the 
cell suspension were added to plasma clots in petri dishes and 0.5-ml aliquots 
to those in multiweUs. At time intervals medium was removed and each clot 
washed twice with  I  ml of FI0 to  remove  non-adherent  cells. The  initial 
medium and two washes were combined and cell number determined  with a 
hemocytometer. 
Cell Spreading Assay 
A drawing-tube attached to an inverted microscope was used to focus the image 
onto a Hi-Pad digitizer tablet (Bausch & Lomb Inc., Rochester, NY) interfaced 
to an Apple 11  plus microcomputer  (Apple Computer Inc., Cupertino,  CA). 
The periphery  of cells were logged via the digitizer, and specifically tailored 
programs were used to compute the longest axis as previously described (t 5). 
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Before the addition  of cell suspensions to plasma clots, 5-ram lengths of 30- 
swg stainless steel wire were bent into right angles and embedded in the surface 
of  clots. 24 h after adding cell suspensions and at four 0.5-h intervals thereafter, 
photomicrographs  were taken  of the area between the arms of the wire right 
angle. 
Enlargements  of the micrographs were prepared and tracings then used to 
plot the migration of each cell in the field at half-hour intervals; the wire right- 
angles were used to orientate tracing overlays. The digitizer and computer were 
then used to measure the distance  migrated per unit time.  BCL-DI  cells are 
very bipolar  and so the  distance  measured  was the difference  betwoen the 
leading point of the cell at each time point. 
Cell Migration into Plasma Clots 
Migration chambers were made from two microscope slides separated by shaped 
1.5-mm  thick  spacers.  Microscope  slides had  previously  been  treated  with 
Siliclad (Becton  Dickinson)  to ensure that  the  chamber had  non-adherent 
surfaces. Calcium and thrombin were added to plasma samples and the mixture 
introduced  into the chambers with a syringe and needle to give a depth  of 1 
cm. The chamber was then incubated  at 37"C for 15 min to ensure complete 
clotting. A suspension of 2 x  104 cells/ml was then added onto each clot with 
a syringe and needle to give a depth of 0.5 cm. The open end of the chamber 
was sealed with dental wax and the chambers then incubated vertically at 37"C. 
After 24 h the chambers were placed horizontally  on a stage of an inverted 
microscope and migration into the clot determined  with the aid of a graticule 
by counting  the number of cells in 0.2-mm intervals from the clot-medium 
interface. 
Diffusion of  Fibronectin  into Plasma Clot 
Plasma clots were formed in plastic tubing of internal diameter 0.5 cm and at 
t =  0,  10 t~l of t2SI-labeled fibronectin  was added to the surface of each clot. 
After incubation  at 37"C for different periods of time, clots were snap-frozen 
and sliced at 1-mm intervals and each slice counted. 
Results 
Plasma clots were prepared from EDTA-plasma after dialysis 
and  recalcification.  Clots  l-mm thick were formed in petri 
dishes and despite their fibrillar nature,  an  inverted phase- 
contrast microscope allowed visualization of ceUs seeded onto 
the surface of the clots. Fresh blood was used throughout this 
study since when outdated blood from the local blood bank 
was used, the clots were visibly less fibrillar and often began 
to lyse before completion of an experiment. 
When suspensions of fibroblasts were seeded in protein-free 
medium onto plasma clots, cells adhered and spread on the 
surface of the fibrin lattice. Fig.  1 shows a photomicrograph 
of BCL-DI cells 6  h  after seeding onto a  plasma clot. The 
fibriUar nature of the clot can be seen. The cells have a more 
spindle-shaped appearance than the same cells  seeded onto 
tissue culture plastic. 
The role of fibronectin in the adhesion  and spreading of 
cells on plasma clots was examined by removing fibronectin 
from fresh plasma by affinity chromatography before clotting. 
In addition to control plasma clots and clots prepared from 
fibronectin-depleted plasma, two further sets of plasma clots 
were used in the following experiments. Purified fibronectin 
was added back to depleted plasma in two ways. The first was 
addition  before  clotting;  this  would  result  in  the  covalent 
cross-linking of fibronectin to fibrin by transglutaminase. The 
second was to clot fibronectin-depleted plasma and then to 
adsorb fibronectin to the resulting clots; in this case fibronec- 
tin  would be physically adsorbed to fibrin and  little if any 
Figure 1.  Human diploid fibroblasts on plasma clots. This photomicrograph was taken using phase-contrast optics of BCL-DI cells 6  h  after 
they were added to a control plasma clot. 
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preparation  of clots.  While  control  plasma  always  clotted 
rapidly when recalcified, fibronectin-depleted plasma clotted 
more slowly since surface-activating proteins  such as Hage- 
man factor also bind to gelatin-affinity columns. 
Fig.  2  shows the  rates of attachment  of BCL-D 1 cells to 
different  plasma  clots.  Rates  of attachment  to  fibronectin- 
depleted clots were slower than to control clots; however, by 
2 h all cells had adhered to both types of clot. When fibronec- 
tin  was  added  back  to depleted  plasma,  then  the  effect of 
depletion was reversed and this was true whether it was added 
before or after clotting. To determine the role of cell surface 
or secreted fibronectin in the adhesion to fibronectin-depleted 
clots,  a  series  of studies  were  done  using  anti-fibronectin 
antiserum.  In initial  experiments a  dilution  of a  polyclonal 
antiserum was found that inhibited the effect of re-addition 
of fibronectin. Fig. 3 shows the effect of the antiserum on the 
adhesion of cells to fibronectin-depleted clots. The antiserum 
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Figure 2. Adhesion of BCL-DI cells to plasma clots. A BCL-D1 cell 
suspension in serum-less medium was added to control plasma clots 
(O), fibronectin-depleted  plasma clots (O), clots formed from fibro- 
nectin-depleted plasma with fibronectin added before clotting (11), or 
clots formed from fibronectin-depleted  plasma with fibronectin  ad- 
sorbed after clotting (O). Cell adhesion was measured at time intervals. 
Each  point represents  the mean of three  observations.  Maximum 
variation between observations was 6%. 
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Figure 3. The effect of anti-fibronectin antiserum on attachment to 
plasma clots. Fibronectin-depleted plasma was used to prepare plasma 
clots with (O, @) or without ([3, II) the addition of fibronectin. A 
suspension of BCL-D 1 cells in serum-less medium was added to the 
clots  with  (O,  l)  or  without  (O,  O)  the  addition  of  polyclonal 
antiserum  to  human  fibronectin at  a  final  dilution  of  1:20.  Cell 
attachment was monitored as in Fig. 2. 
abolishes the effect of re-added fibronectin but has no effect 
on the ultimate ability of all cells to adhere. 
When depleted samples of plasma were subjected to SDS 
gel electrophoresis followed by electroblotting and detection 
with anti-fibronectin antiserum, no fibronectin was detecta- 
ble. To rule out the possibility of traces of fibronectin remain- 
ing after affinity chromatography, samples of  depleted plasma 
were rechromatographed using gelatin affinity columns, and 
polyclonal anti-human  plasma  fibronectin  antibodies  were 
added  before  clotting.  There  was  no  signifcant  difference 
between the results  obtained using this plasma and plasma 
that had been passed once through excess affinity gel. 
Cell spreading was measured morphometricaUy by focusing 
the phase-contrast microscope image onto a  digitizer tablet 
interfaced to a microcomputer. Fig. 4 shows that cells spread 
on fibronectin-depleted plasma clots at slower rates than on 
control  clots.  As  in  the  case  of attachment  this  is  only a 
transient difference and with time both sets of clots became 
indistinguishable.  In  the  case  of re-addition  of fibronectin 
there was a clear difference between fibronectin added before 
and after clotting. Only in the case of addition before clotting 
was the rate of spreading the same as controls and clots to 
which  fibronectin  had  been  added  after  dotting  behaved 
essentially like fibronectin-depleted plasma clots. 
Two aspects of migration were studied.  Migration on the 
surface of the clot was studied by taking photomicrographs of 
marked  fields  at  time  intervals  and  using  the  digitizer  to 
measure rate of locomotion. These measurements were made 
1 d after seeding cells onto the surface of the clots and so cells 
were by this time equally well spread on control and fibro- 
nectin-depleted clots. Table I shows that fibronectin depletion 
had no effect on the rate of migration over the surface of a 
clot. 
To  measure  migration  into  clots,  chambers  were  made 
using silicone-treated glass.  The chambers were constructed 
so that they could be incubated vertically to allow suspended 
cells  to  settle  onto the  surface of the  clot.  Fig.  5  shows a 
diagram of the chamber. Cells were added to the surface of 
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Figure 4. The spreading of BCL-DI cells on plasma clots. A BCL-DI 
cell suspension in serum-less medium was added to control plasma 
clots (O), fibronectin-depleted  plasma  clots (O), clots formed from 
fibronectin-depleted  plasma  with fibronectin  added  before clotting 
(ll), or clots formed from fibronectin-depleted plasma with fibronec- 
tin adsorbed after clotting (O). Cell spreading was measured morpho- 
metrically at time intervals. Results represent the mean -+ one stand- 
ard deviation of 20 cells on each of triplicate clots (i.e., 60 cells in 
total). 
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Migration 0~m/h) 
Exp. no.  Control plasma clots  Fibroneetin-depleted clots 
1  78 _+ 6  85 -  13 
2  65 +  8  72 __. 8 
3  85+  12  79+  11 
4  99+6  87 _+ 13 
In four separate experiments plasma clots and fibronectin-depleted clots were 
prepared from the blood of four different volunteers. Each results represent the 
mean +  SD of 20 cells on duplicate clots measured over four 30-min periods. 
Figure 5.  Diagram of the chambers used to study migration into 
plasma clots. 
the clot in serum-less medium and at timed intervals cham- 
bers were  turned  through  90*  and placed on  a  microscope 
stage to measure migration of cells into the clot. Cells failed 
to adhere to the siliconized glass used for construction of the 
chambers and so any migration must have occurred through 
the fibrin lattice of the clots. 
Fig. 6 shows a photomicrograph of BCL-D 1 cells migrating 
within a  control plasma clot. Cells have long processes and 
show non-uniform morphology. The cells that appear spher- 
ical in shape are in fact cells spread along the axis of viewing; 
this is established by focusing at  different levels within the 
clot. 
Fig. 7 shows the results of a  typical experiment measuring 
migration into different clots. While fibroblasts moved rapidly 
into  control clots,  cells were  completely unable  to  migrate 
into fibronectin-depleted clots. In chambers containing fibro- 
nectin-depleted clots, cells adhered, spread, and migrated over 
the surface of the clot but failed even after a  3-d incubation 
to  penetrate into  the  fibrin lattice. Addition of fibronectin 
before clotting completely reversed the  effect of depletion. 
Adsorption of fibronectin to the plasma clot failed to reverse 
depletion and again cells failed to enter the fibrin mesh. Even 
adsorption of fibronectin for 24 h before the addition of cells 
failed to reverse the effect of depletion, and no cells migrated 
into the clot. The rates of migration shown in Fig. 7 appear 
to be less than those in Table I. The reason is that fibroblasts 
show random migratory patterns and the data in Table I refer 
to  absolute  migration,  whereas  that  in  Fig.  7  concern  net 
movement. 
Since fibronectin binds to fibrin, it was necessary to estab- 
lish that  fibronectin, when  added to  the  surface  of a  clot, 
diffused through  the  fibrin  mesh.  This  was  achieved using 
Figure 6. Photomicrograph of cells migrating through a plasma clot. 
A cell  suspension was added to the surface of  plasma clots in migration 
chambers. After incubation at 37"C for 24 h, a chamber was turned 
through 90* and placed on the stage  of a  microscope and photo- 
graphed with phase-contrast optics. 
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Figure 7. Migration of fibroblasts into plasma clots. Migration cham- 
bers were prepared containing (a) control plasma clots, (b) fibronec- 
tin-depleted plasma clots, (c) clots formed from fibronectin-depleted 
plasma with fibronectin adsorbed after dotting, or (d) clots formed 
from fibronectin-depleted  plasma with fibronectin added before clot- 
ting.  After adding cell suspensions and sealing the open end, the 
chambers were incubated vertically for 24 h at which time they were 
turned through 90", placed on the stage of a  microscope, and the 
number of cells migrating regular distances from the clot/medium 
interface measured with the aid of a graticule. 
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Figure 8. Diffusion of  fibronectin into plasma clots. Replicate plasma 
clots were formed from fibronectin-depleted plasma. After adding 
radiolabeled fibronectin to the surface of clots, they were incubated 
at 37°C. At 4 h (l'q), 8 h (@), and 24 h (O) clots were snap-frozen, 
sliced, and counted. 
radioiodinated fibronectin which was added to the surface of 
plasma clots. Fig. 8 shows the extent to which fibronectin had 
diffused into clots at different time intervals. SDS gel electro- 
phoresis and autoradiography was used to confirm that >98% 
of label diffusing into the clots was native fibronectin, and 
autoradiography of slices of clot was used to confirm that 
fibronectin diffused uniformly throughout the clot. 
Discussion 
During a  wound  response, cells migrate into  the coagulum 
formed at the  site of tissue damage.  Here it  is  shown that 
plasma fibronectin is necessary for the migration of fibroblasts 
into plasma clots. The role played by fibronectin is complex. 
Although necessary for migration into clots, it is not necessary 
for the attachment and spreading of cells  on the surface of 
fbrin  since  when clots were prepared from fibronectin-de- 
pleted plasma, there were only small differences in initial rates 
of adhesion. Migration over the surface of plasma clots was 
also unaffected by removal of fibronectin. Antisera to fibro- 
nectin  did  not  prevent  adhesion  to  fibronectin-depleted 
plasma clots, suggesting that the cells can adhere and spread 
via mechanisms that do not involve plasma or cellular fibro- 
nectin,  although  fibronectin  can  mediate  adhesion  to  ad- 
sorbed monomolecular layers of fibrin (9). Fibronectin is not 
essential for the adhesion of cells to tissue culture plastic (11, 
32) or to collagen (8, 26), and there is in plasma at least one 
other adhesive glycoprotein known as serum spreading factor 
(vitronectin) (2,  10,  17, 30), which is unrelated to fibronectin 
and stimulates adhesion via a different mechanism (15,  18). 
The requirement for fibronectin in  migration into  a  clot 
was absolute. Cells failed, even over extended time courses, 
to  migrate  into  clots  formed  from  fibronectin-depleted 
plasma. This effect was reversed by the addition  of purified 
fibronectin  before  clotting,  suggesting  that  the  fibronectin 
needs to  be covalently cross-linked to  fibrin by transgluta- 
minase. The importance of this enzyme has been demonstra- 
ted in vitro (4,  14, 33) where optimal growth on clots requires 
the  presence of the  enzyme.  Individuals with  an  inherited 
deficiency of the enzyme display poor wound-healing (1, 6). 
The results using fibronectin added after clotting of  depleted 
plasma are only valid if the fibronectin has diffused into the 
matrix of the clot. This was confirmed using radioiodinated 
fibronectin.  The  fact that  serum contains only slightly  less 
fibronectin than plasma indicates that only a small percentage 
of the total plasma concentration becomes involved in fibrin 
formation.  Fibronectin  diffused  rapidly into  depleted  clots 
and  the  diffusion  coefficient was calculated  as  0.9  x  l0  -7 
cm2/s. This is not significantly different from the value that 
would  be  expected  in  water.  Using  the  data  from  studies 
involving  the  migration  of cells  into  clots,  an  equivalent 
diffusion coefficient of over  108  cm2/s was  obtained.  This 
indicates that even if fibronectin and cells were added at the 
same time that the diffusion of fibronectin would not be rate- 
limiting in relation to cell migration. In fact, in some of the 
reported experiments, fibronectin was added 24 h before the 
cells. 
The structure of the fibronectin molecule has been studied 
in detail. The protein contains a domain that includes a fbrin- 
binding region  (27,  28) and  a  domain  that  includes  a  cell 
surface  binding  site  (7,  25).  The  two  binding  sites  of the 
protein would seem to offer an obvious mechanism in which 
the cross-linked fibronectin provides the points of adhesion 
for cells on the fibrin lattice. However, the results here show 
that  fibroblasts can  adhere,  spread,  and  migrate on  fibrin 
lattices in  the  absence of fibronectin.  Thus,  there  must be 
other sites on  the  fibrin  lattice  to which  cells  can  become 
attached. 
The cross-linking of fibronectin to fibrin is known to affect 
the physical characteristics of the clot. Thus, the shear mod- 
ulus of fibrin is increased by the cross-linking of fibronectin 
(13). 
Cells  could migrate on the surface of clots in the absence 
of  fibronectin and so it is necessary to question the mechanism 
in which fibronectin promotes migration into plasma clots. 
Recently it has been shown that fibronectin brings about a 
rapid  movement  of cells  from  collagen  gels  that  did  not 
contain  fibronectin  into  contiguous  areas  of gel  that  did 
contain physiological concentrations of fibronectin (22). This 
translocation of cells was a function of the chemimechanical 
properties of the matrix in that polystyrene beads were also 
found to move rapidly but  only during periods of collagen 
fibrillogenesis.  Although we report here that fibronectin brings 
about a  movement of cells into a  fibrin mesh, it is unlikely 
that the mechanism involves "matrix-driven translocation." 
First, cells were not added until after the completion of fbrin 
fibrillogenesis.  Second,  matrix-driven translocation is unidi- 
rectional, whereas migration in plasma clots is random. Cells 
in plasma clots showed a non-uniform morphology. However, 
within  the  lattice  structure  of a  clot,  fibroblasts assume  a 
three-dimensional configuration, whereas on a solid substra- 
tum the morphology is essentially two-dimensional. 
In vivo, it is possible that  cell  migration  is  chemotactic. 
Platelet-derived  growth  factor  has  been  shown  to  exert  a 
chemotactic influence on fibroblasts (29). Platelet factors were 
not present in the plasma clots used in the studies reported 
here.  We  intend  to  now study the  effects of platelets  and 
platelet factors in fibroblast migration into clots. 
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